Form 4 for BJDX Bluejay Diagnostics, Inc.
Accepted 2022-03-18 00:00:00 ET · period of report 2022-03-17 · accession 0001213900-22-013510 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-18 | 2022-03-17 | BJDX | Wurth Douglas Clark | Dir, 10% | P - Purchase | $1.18 | +40.0K | 2.29M | +2% | +$47.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-17 | P | A | 40,000 | $1.18 | 2,286,349 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $1.15 to $1.20. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Does not include 1,108,883 shares held indirectly by Wurth Holdings, LLC. |